These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17203649)

  • 1. Conditional somatic mutagenesis in the mouse using site-specific recombinases.
    Feil R
    Handb Exp Pharmacol; 2007; (178):3-28. PubMed ID: 17203649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific recombinases for manipulation of the mouse genome.
    Birling MC; Gofflot F; Warot X
    Methods Mol Biol; 2009; 561():245-63. PubMed ID: 19504076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2.
    Anastassiadis K; Glaser S; Kranz A; Berhardt K; Stewart AF
    Methods Enzymol; 2010; 477():109-23. PubMed ID: 20699139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cre recombinase resources for conditional mouse mutagenesis.
    Smedley D; Salimova E; Rosenthal N
    Methods; 2011 Apr; 53(4):411-6. PubMed ID: 21195764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering embryonic stem cells with recombinase systems.
    Schnütgen F; Stewart AF; von Melchner H; Anastassiadis K
    Methods Enzymol; 2006; 420():100-36. PubMed ID: 17161696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombineering pipeline to make conditional targeting constructs.
    Fu J; Teucher M; Anastassiadis K; Skarnes W; Stewart AF
    Methods Enzymol; 2010; 477():125-44. PubMed ID: 20699140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cre/loxP-mediated chromosome engineering of the mouse genome.
    Brault V; Besson V; Magnol L; Duchon A; Hérault Y
    Handb Exp Pharmacol; 2007; (178):29-48. PubMed ID: 17203650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Site-specific recombinases in genetic engineering: modern in vivo technologies].
    Ostash B
    Tsitol Genet; 2010; 44(4):61-9. PubMed ID: 20722288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific recombination of asymmetric lox sites mediated by a heterotetrameric Cre recombinase complex.
    Saraf-Levy T; Santoro SW; Volpin H; Kushnirsky T; Eyal Y; Schultz PG; Gidoni D; Carmi N
    Bioorg Med Chem; 2006 May; 14(9):3081-9. PubMed ID: 16412655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-activated Flpe for temporally regulated gene modifications.
    Hunter NL; Awatramani RB; Farley FW; Dymecki SM
    Genesis; 2005 Mar; 41(3):99-109. PubMed ID: 15729687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis.
    Zhang M; Kirsch DG
    Dis Model Mech; 2015 Sep; 8(9):1155-66. PubMed ID: 26183214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene deletion from Plasmodium falciparum using FLP and Cre recombinases: implications for applied site-specific recombination.
    O'Neill MT; Phuong T; Healer J; Richard D; Cowman AF
    Int J Parasitol; 2011 Jan; 41(1):117-23. PubMed ID: 20816845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PhiC31 integrase facilitates genetic approaches combining multiple recombinases.
    Monetti C; Nishino K; Biechele S; Zhang P; Baba T; Woltjen K; Nagy A
    Methods; 2011 Apr; 53(4):380-5. PubMed ID: 21185379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible Cre mice.
    Feil S; Valtcheva N; Feil R
    Methods Mol Biol; 2009; 530():343-63. PubMed ID: 19266339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues.
    Hameyer D; Loonstra A; Eshkind L; Schmitt S; Antunes C; Groen A; Bindels E; Jonkers J; Krimpenfort P; Meuwissen R; Rijswijk L; Bex A; Berns A; Bockamp E
    Physiol Genomics; 2007 Sep; 31(1):32-41. PubMed ID: 17456738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional mouse models of sporadic cancer.
    Jonkers J; Berns A
    Nat Rev Cancer; 2002 Apr; 2(4):251-65. PubMed ID: 12001987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Of mice and models: improved animal models for biomedical research.
    Bockamp E; Maringer M; Spangenberg C; Fees S; Fraser S; Eshkind L; Oesch F; Zabel B
    Physiol Genomics; 2002 Dec; 11(3):115-32. PubMed ID: 12464688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering cell-permeant FLP recombinase for tightly controlled inducible and reversible overexpression in embryonic stem cells.
    Patsch C; Peitz M; Otte DM; Kesseler D; Jungverdorben J; Wunderlich FT; Brüstle O; Zimmer A; Edenhofer F
    Stem Cells; 2010 May; 28(5):894-902. PubMed ID: 20333748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional mutagenesis by cell-permeable proteins: potential, limitations and prospects.
    Patsch C; Edenhofer F
    Handb Exp Pharmacol; 2007; (178):203-32. PubMed ID: 17203657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current issues in mouse genome engineering.
    Glaser S; Anastassiadis K; Stewart AF
    Nat Genet; 2005 Nov; 37(11):1187-93. PubMed ID: 16254565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.